Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells

Biological Chemistry

Volumn 382, Issue 4, 2001, Pages 655-660

  Feng, Ying ^a   Kong, Yu Ying ^a   Wang, Yuan ^a   Qi, Guorong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Antiviral; Hammerhead ribozyme; HBV; Poly(A) signal; Viral replication

Indexed keywords

NUCLEIC ACID BASE; POLYADENYLIC ACID; PROTEIN ADR; RIBOZYME; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME RELEASE; GENE MUTATION; GENE THERAPY; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; PRIORITY JOURNAL; PROGENY; PROTEIN TARGETING; RNA DEGRADATION; VIRUS INFECTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; POLY A; PROTEIN SORTING SIGNALS; RNA, CATALYTIC; RNA, VIRAL; TRANSFECTION; TUMOR CELLS, CULTURED;

HEPATITIS B VIRUS;

EID: 0034998545     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.077     Document Type: Article

References (24)

1. Bartolome, J.A., Madejon, and Carreno, V. (1995). Ribozymes: structure, characteristics and use as potential antiviral agents. J. Hepatol. 22, 57-64.
2. Beck, J., and Nassal, M. (1995). Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res. 23, 4954-4962.
3. Cameron, F.H., and Jennings, P.A. (1989). Specific gene suppression by engineered ribozymes in Monkey cells. Proc. Natl. Acad. Sci. USA 86, 9139-9143.
4. Encke, J., zu Putlitz, J., and Wands, J.R. (1999). DNA vaccines. Intervirology 42, 117-124.
5. Fu, L., Wu, X., Kong, Y.Y., and Wang, Y. (1997). Regulation of HBV gene expression by core promoter and its upstream sequence. Chinese J. Virol. 13, 215-223.
6. He, Y.K., Lu, C.D., and Qi, G.R. (1993). In vitro cleavage of HPV E6 and E7 RNA fragments by synthetic ribozymes and transcribed ribozymes from RNA-trimming plasmids. FEBS Lett. 322, 21-24.
7. Kim, Y.K., Junn, E., Park, I., Lee, Y., Kang, C., and Ahn, J.K. (1999). Repression of hepatitis B virus X gene expression by hammerhead ribozymes. Biochem. Biophys. Res. Commun. 257, 759-765.
8. Lu, C.D., Chen, N.A., and Qi, G.R. (1997). Computer analysis of the cleavage reaction of hammerhead ribozyme. Chinese J. Biochem. Biophys. 29, 77-84.
9. Malik, A.H., and Lee, W.M. (2000). Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann. Intern. Med. 2, 723-731.
10. Nakazono, K., Ito, Y., Wu, C.H., and Wu, G.Y. (1996). Inhibition of Hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Hepatology 23, 1297-1303.
11. Paran, N., Ori, A., Haviv, I., and Shaul, Y. (2000). A composite polyadenylation signal with TATA box function. Mol. Cell. Biol. 20, 834-841.
12. Robinson, W.S. (1994). Molecular events in the pathogenesis of hepadnavirus associated hepatocellular carcinoma. Annu. Rev. Med. 45, 297-323.
13. Ruiz, J., Wu, C.H., Ito, Y., and Wu, G.Y. (1997). Design and preparation of a multimeric self-cleaving hammerhead ribozyme. Biotechniques 22, 338-345.
14. nd Edition (Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press).
15. Siddiqui, A. (1991). Transcription of hepadnaviruses. In: Molecular Biology of the Hepatitis B Virus, A. Mclachlan, ed. (Boca Raton, USA: CRC Press, Inc.), pp. 96-105.
16. Summers, J., Smith, P.M., Huang, M.J., and Yu, M.S. (1991). Morphogenetic and regulatory effects of mutations in the envelop proteins of an avian hepadnavirus. J. Virol. 65, 1310-1317.
17. Symons, R.H. (1992). Small catalytic RNAs. Annu. Rev. Biochem. 61, 641-671.
18. Weinberg, M., Passman, M., Kew, M., and Arbuthnot, P. (2000). Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells. J. Hepatol. 33, 142-151.
19. Welch, P.J., Tritz, R., Yei, S., Barber, J., and Yu, M. (1997). Intracellular application of haripin ribozyme genes against hepatitis B Virus. Gene Therapy 4, 736-743.
20. Wu, G.Y., and Wu, C.H. (1992). Specific inhibition of Hepatitis B viral gene expression in vitro by targeted antisense oligonuleotides. J. Biol. Chem. 267, 12436-12439.
21. Zheng, W.C., and Qi, G.R. (1999). Anti-HBV activity of tRNA-embedded ribozymes in HepG2 cells. Chinese J. Biochem. Mol. Biol. 15, 563-566.
22. Zhu, L.F., Yi, R.D., Lu, C.D., Wang, Y., and Qi, G.R. (1993). Ribozyme that cleaves site-specifically the RNA fragment derived from core antigen gene of hepatitis B virus subtype adr in vitro. Chinese J. Biochem. Biophys. 25, 313-317.
23. Zoulim, F., and Trepo, C.(1999). New antiviral agents for the therapy of chronic hepatitis B virus infection. Intervirology 42, 125-144.
24. zu Putlitz, J., Yu, Q., Burke, J.M., and Wands, J.R. (1999). Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus. J. Virol. 73, 5381-5387.